ArticleFrontiers in medicine2026
Diagnostic performance of ultrasonographic medial gastrocnemius muscle thickness for sarcopenia in patients on maintenance hemodialysis.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The study aimed to evaluate the performance of ultrasonographic medial gastrocnemius muscle thickness (MGMT) and pennation angle (MGMPA) in diagnosing sarcopenia among patients on maintenance hemodialysis (MHD). Methods: The MGMT and MGMPA were measured ultrasonographically. Baseline characteristics were compared between the sarcopenia and non-sarcopenia groups. Correlations between ultrasound parameters and sarcopenia indicators were evaluated. The diagnostic performance of the ultrasound parameters was assessed using receiver operating characteristic (ROC) curve analysis. Multivariable logistic regression analysis was conducted to identify independent predictors associated with sarcopenia, followed by the construction and validation of a diagnostic nomogram. Additionally, bootstrap mediation analysis assessed the direct and indirect effects of sonographic parameters on sarcopenia. Results: This study cohort comprised 221 MHD patients. Both MGMT (12.8 vs. 16.5 mm, Conclusion: Ultrasonographic measurement of MGMT demonstrates high diagnostic performance and serves as a reliable, independent predictor for sarcopenia in patients undergoing maintenance hemodialysis, highlighting its potential as a practical, non-invasive screening tool in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.